GLOBAL MEDICAL REIT INC (GMRE) Stock Earnings & Estimates
USA - New York Stock Exchange - NYSE:GMRE - US37954A3032 - REIT
36.11 USD
+0.04 (+0.11%)
36.11 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 137.3M 18.46% | 141.049M 2.73% | 138.78M -1.61% | 149.15M 7.47% | 153.89M 3.18% | 159.4M 3.58% | 161.47M 1.30% | |
| EBITDA YoY % growth | 95.44M 13.63% | 95.936M 0.52% | 87.96M -8.31% | 98.019M 11.44% | 102.97M 5.05% | 104.97M 1.94% | 107.92M 2.81% | |
| EBIT YoY % growth | 38.8M 4.30% | 37.979M -2.12% | 33.047M -12.99% | 38.001M 14.99% | 40.322M 6.11% | 44.982M 11.56% | 47.328M 5.22% | |
| Operating Margin | 28.26% | 26.93% | 23.81% | 25.48% | 26.20% | 28.22% | 29.31% | |
| EPS YoY % growth | 1.00 5.26% | 1.15 15.00% | 0.20 -82.61% | 0.28 39.40% | 0.12 -58.54% | 0.24 111.77% | 0.09 -62.50% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.03 -86.40% | 0.03 -79.60% | 0.02 130.60% | -0.03 -253.00% | -0.02 -160.01% | 0.00 -100.00% | 0.01 -33.33% | 0.03 200.00% | 0.04 300.00% |
| Revenue Q2Q % growth | 37.935M 7.90% | 38.214M 10.39% | 38.679M 1.87% | 38.859M 4.38% | 39.098M 3.07% | 41.12M 7.60% | 41.866M 8.24% | 42.612M 9.66% | 43.358M 10.90% |
| EBITDA Q2Q % growth | 26.034M -57.39% | 26.381M 13.81% | 26.818M -27.71% | 27.1M -48.43% | 27.511M 5.67% | 28.025M 6.23% | 28.61M 6.68% | 28.94M 6.79% | 29.526M 7.32% |
| EBIT Q2Q % growth | 9.409M 42.34% | 9.589M 0.03% | 9.707M 15.05% | 9.786M 7.10% | 9.828M 4.45% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 0.02 -86.67% | 0.05 | -0.03 | -57.99% |
| Q2 2025 Q2Q % growth | -0.05 80.00% | 0.15 | -0.20 | -132.68% |
| Q1 2025 Q2Q % growth | 0.15 200.00% | 0.06 | 0.09 | 135.29% |
| Q4 2024 Q2Q % growth | 0.25 600.00% | 0.00 | 0.25 | % |
| Q3 2024 Q2Q % growth | 0.15 -40.00% | 0.12 | 0.03 | 26.07% |
| Q2 2024 Q2Q % growth | -0.25 -127.78% | 0.00 | -0.25 | % |
| Q1 2024 Q2Q % growth | 0.05 | 0.02 | 0.03 | 194.41% |
| Q4 2023 Q2Q % growth | -0.05 -200.00% | 0.08 | -0.13 | -165.36% |
| Q3 2023 Q2Q % growth | 0.25 -58.33% | 0.07 | 0.18 | 250.14% |
| Q2 2023 Q2Q % growth | 0.90 500.00% | 0.08 | 0.82 | 1,076.47% |
| Q1 2023 Q2Q % growth | 0.05 -75.00% | 0.08 | -0.03 | -34.64% |
| Q4 2022 Q2Q % growth | 0.05 -83.33% | 0.14 | -0.09 | -64.35% |
| Q3 2022 Q2Q % growth | 0.60 100.00% | 0.18 | 0.42 | 226.80% |
| Q2 2022 Q2Q % growth | 0.15 -25.00% | 0.24 | -0.09 | -38.08% |
| Q1 2022 Q2Q % growth | 0.20 33.33% | 0.27 | -0.07 | -26.47% |
| Q4 2021 Q2Q % growth | 0.30 200.00% | 0.35 | -0.05 | -13.49% |
| Q3 2021 Q2Q % growth | 0.30 50.00% | 0.28 | 0.02 | 6.95% |
| Q2 2021 Q2Q % growth | 0.20 | 0.24 | -0.04 | -18.30% |
| Q1 2021 Q2Q % growth | 0.15 | 0.18 | -0.03 | -15.97% |
| Q4 2020 Q2Q % growth | 0.10 | 0.20 | -0.10 | -50.98% |
| Q3 2020 Q2Q % growth | 0.20 | -0.62 | 0.82 | 132.14% |
| Q2 2020 Q2Q % growth | 0.00 | 0.17 | -0.17 | -100.00% |
| Q1 2020 Q2Q % growth | 0.15 | 0.19 | -0.04 | -19.79% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 37.229M 8.65% | 38.917M | -1.688M | -4.34% |
| Q2 2025 Q2Q % growth | 37.969M 10.89% | 36.08M | 1.889M | 5.24% |
| Q1 2025 Q2Q % growth | 34.618M -1.42% | 36.089M | -1.471M | -4.08% |
| Q4 2024 Q2Q % growth | 35.157M 6.66% | 35.32M | -163K | -0.46% |
| Q3 2024 Q2Q % growth | 34.264M -3.50% | 35.338M | -1.074M | -3.04% |
| Q2 2024 Q2Q % growth | 34.241M -5.80% | 35.125M | -884K | -2.52% |
| Q1 2024 Q2Q % growth | 35.118M -3.07% | 34.617M | 501K | 1.45% |
| Q4 2023 Q2Q % growth | 32.962M -9.22% | 36.353M | -3.391M | -9.33% |
| Q3 2023 Q2Q % growth | 35.507M 0.27% | 36.72M | -1.213M | -3.30% |
| Q2 2023 Q2Q % growth | 36.351M 7.87% | 37.021M | -670K | -1.81% |
| Q1 2023 Q2Q % growth | 36.23M 13.64% | 37.347M | -1.117M | -2.99% |
| Q4 2022 Q2Q % growth | 36.31M 19.68% | 36.669M | -359K | -0.98% |
| Q3 2022 Q2Q % growth | 35.41M 18.11% | 35.424M | -14K | -0.04% |
| Q2 2022 Q2Q % growth | 33.7M 19.25% | 33.457M | 243K | 0.73% |
| Q1 2022 Q2Q % growth | 31.88M 16.56% | 32.058M | -178K | -0.56% |
| Q4 2021 Q2Q % growth | 30.34M 21.70% | 31.235M | -895K | -2.87% |
| Q3 2021 Q2Q % growth | 29.98M 19.44% | 29.875M | 105K | 0.35% |
| Q2 2021 Q2Q % growth | 28.26M 28.11% | 29.204M | -944K | -3.23% |
| Q1 2021 Q2Q % growth | 27.35M 26.33% | 26.277M | 1.073M | 4.08% |
| Q4 2020 Q2Q % growth | 24.93M | 26.12M | -1.19M | -4.56% |
| Q3 2020 Q2Q % growth | 25.1M | 23.137M | 1.963M | 8.48% |
| Q2 2020 Q2Q % growth | 22.06M | 22.344M | -284K | -1.27% |
| Q1 2020 Q2Q % growth | 21.65M | 21.68M | -30K | -0.14% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -33.34% | 0% | 446.66% |
| Revenue | 0% | -0.98% | 0% | -0.67% |